• Illumina Inc ILMN.OQ reported quarterly adjusted earnings of 86 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of 14 cents. The mean expectation of twenty one analysts for the quarter was for earnings of 91 cents per share. Wall Street expected results to range from 89 cents to 93 cents per share.

• Revenue fell 1.6% to $1.10 billion from a year ago; analysts expected $1.08 billion.

• Illumina Inc's reported EPS for the quarter was $1.17​.

• The company reported quarterly net income of $187 million.

• Illumina Inc shares had fallen by 6.7% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 0.4% in the last three months.​

• In the last 30 days, three analysts negatively revised earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy," 12 "hold" and 1 "sell" or "strong sell."

• The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for Illumina Inc is $162.00

This summary was machine generated from LSEG data February 6 at 10:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)